Publications

2024

Rothenberg-Lausell C, Bar J, Del Duca E, Guttman-Yassky E.

Diversity of atopic dermatitis and selection of immune targets.

Ann Allergy Asthma Immunol. 2024 Feb

DOI: 10.1016/j.anai.2023.11.020

Leung DYM, Facheris P, Veverka KA, Cevikbas F, Guttman-Yassky E.

Targeting type 2 immune activation beyond atopic dermatitis

Ann Allergy Asthma Immunol. 2024 Feb.

DOI: 10.1016/j.anai.2023.06.028

Del Duca E, Dahabreh D, Kim M, Bar J, Da Rosa JC, Rabinowitz G, Facheris P, Gómez-Arias PJ, Chang A, Utti V, Chowdhury A, Liu Y, Estrada YD, Laculiceanu A, Agache I, Guttman-Yassky E.

Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities

Allergy. 2024 Jun.

DOI: 10.1111/all.16060

Croft M, Esfandiari E, Chong C, Hsu H, Kabashima K, Kricorian G, Warren RB, Wollenberg A, Guttman-Yassky E.

Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target

Am J Clin Dermatol. 2024 May.

DOI: 0.1007/s40257-024-00850-7

 

Hawkins K, David E, Glickman JW, Del Duca E, Guttman-Yassky E, Krueger JG.

Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling.

Expert Rev Clin Immunol. 2024 Mar.

DOI: 10.1080/1744666X.2024.2323964

Navrazhina K, Renert-Yuval Y, Khattri S, Hamade H, Meariman M, Andrews E, Kim M, NandyMazumdar M, Gour DS, Bose S, Williams SC, Garcet S, Correa da Rosa J, Gottlieb AB, Krueger JG, Guttman-Yassky E.

Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa.

J Am Acad Dermatol. 2024 Apr

DOI: 10.1016/j.jaad.2023.11.048

2023

Guttman-Yassky E, Facheris P, Gomez-Arias PJ, Del Duca E, Da Rosa JC, Weidinger S, Bissonnette R, Armstrong AW, Seneschal J, Eyerich K, Estrada YD, Bose SN, Xu D, Chen A, Tatulych S, Güler E, Chan G, Page KM, Kerkmann U.

Effect of abrocitinib on skin biomarkers in patients with moederate-to-severe atopic dermatitis.

Allergy. 2023

DOI: 10.1111/all.15969

Bissonnette R, DuBois J, Facheris P, Del Duca E, Kim M, Correa Da Rosa J, Trujillo DL, Bose S, Pagan AD, Wustrow D, Brockstedt DG, Wong B, Kassner PD, Jankicevic J, Ho W, Cheng LE, Guttman-Yassky E.

Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study

Allergy. 2023

DOI: 10.1111/all.15949

Guttman-Yassky E, Del Duca E, Da Rosa JC, Bar J, Ezzedine K, Ye Z, He W, Hyde C, Hassan-Zahraee M, Yamaguchi Y, Peeva E.

Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo.

J Allergy Clin Immunol. 2024 Jan

DOI: 10.1016/j.jaci.2023.09.021

Kim M, Renert-Yuval Y, Stepensky P, Even-Or E, Zaidman I, Fachler T, Neumark M, Zamir M, NandyMazumdar M, Gour D, Facheris P, Carroll B, Liu Y, Yu Ekey ML, Andrews E, Meariman M, Angelov M, Bose S, Estrada YD, Molho-Pessach V, Guttman-Yassky E.

Sclerotic-type cutaneous chronic graft-versus-host disease exhibitis activation of T helper 1 and OX40 cytokines.

J Invest Dermatol. 2023 Sep

DOI: 10.1016/j.jid.2023.08.026

Renert-Yuval Y, Del Duca E, Arents B, Bissonnette R, Drucker AM, Flohr C, Guttman-Yassky E, Hijnen D, Kabashima K, Leshem YA, Paller AS, Silverberg JI, Simpson EL, Spuls P, Vestergaard C, Wollenberg A, Irvine AD, Thyssen JP.

Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis

J Eur Acad Dermatol Venereol. 2024 Jan

DOI: 10.1111/jdv.19506

Dahabreh D, Jung S, Renert-Yuval Y, Bar J, Del Duca E, Guttman-Yassky E.

Alopecia areata: Current treatments and new directions

Am J Clin Dermatol. 2023 Nov

DOI: 10.1007/s40257-023-00808-1

Del Duca E, He H, Liu Y, Pagan AD, David E, Cheng J, Carroll B, Renert-Yuval Y, Bar J, Estrada YD, Maari C, Proulx ES, Krueger JG, Bissonnette R, Guttman-Yassky E.

Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies

Allergy. 2024 Jan

DOI: 10.1111/all.15845

Kim M, Renert-Yuval Y, Stepensky P, Even-Or E, Zaidman I, Fachler T, Neumark M, Zamir M, NandyMazumdar M, Gour D, Facheris P, Carroll B, Liu Y, Yu Ekey ML, Andrews E, Meariman M, Angelov M, Bose S, Estrada YD, Molho-Pessach V, Guttman-Yassky E.

Sclerotic-type cutaneous chronic graft-versus-host disease exhibitis activation of T helper 1 and OX40 cytokines.

J Invest Dermatol. 2023 Sep

DOI: 10.1016/j.jid.2023.08.026